The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $19.88 in the last session, down -2.60% from day before closing price of $20.41. In other words, the price has decreased by -$2.60 from its previous closing price. On the day, 0.68 million shares were traded. ZLAB stock price reached its highest trading level at $20.25 during the session, while it also had its lowest trading level at $19.82.
Ratios:
We take a closer look at ZLAB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.68 and its Current Ratio is at 2.87. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $55. BofA Securities Downgraded its Buy to Neutral on March 03, 2025, whereas the target price for the stock was revised from $29 to $36.10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 21 ’25 when Edmondson Frazor Titus III sold 14,328 shares for $19.78 per share. The transaction valued at 283,408 led to the insider holds 27,737 shares of the business.
Edmondson Frazor Titus III bought 14,328 shares of ZLAB for $283,408 on Nov 21 ’25. On Nov 03 ’25, another insider, Chen Yajing, who serves as the Chief Financial Officer of the company, sold 240 shares for $26.83 each. As a result, the insider received 6,439 and left with 17,444 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 2198603776 and an Enterprise Value of 21488246784. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.00 while its Price-to-Book (P/B) ratio in mrq is 2.89. Its current Enterprise Value per Revenue stands at 48.657 whereas that against EBITDA is -100.51.
Stock Price History:
The Beta on a monthly basis for ZLAB is 0.87, which has changed by -0.32327586 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $44.34, while it has fallen to a 52-week low of $19.51. The 50-Day Moving Average of the stock is -26.03%, while the 200-Day Moving Average is calculated to be -38.25%.
Shares Statistics:
According to the various share statistics, ZLAB traded on average about 835.58K shares per day over the past 3-months and 897640 shares per day over the past 10 days. A total of 110.59M shares are outstanding, with a floating share count of 108.86M. Insiders hold about 2.12% of the company’s shares, while institutions hold 30.62% stake in the company. Shares short for ZLAB as of 1763078400 were 4603118 with a Short Ratio of 5.51, compared to 1760486400 on 4811176. Therefore, it implies a Short% of Shares Outstanding of 4603118 and a Short% of Float of 4.7199998.
Earnings Estimates
. The current market rating for Zai Lab Limited ADR (ZLAB) reflects the collective analysis of 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.23 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$1.36 and -$2.05 for the fiscal current year, implying an average EPS of -$1.61. EPS for the following year is -$0.56, with 9.0 analysts recommending between $0.55 and -$1.93.
Revenue Estimates
According to 5 analysts,. The current quarter’s revenue is expected to be $127.07M. It ranges from a high estimate of $128.4M to a low estimate of $124.4M. As of. The current estimate, Zai Lab Limited ADR’s year-ago sales were $109.07MFor the next quarter, 5 analysts are estimating revenue of $130.3M. There is a high estimate of $130.3M for the next quarter, whereas the lowest estimate is $130.3M.
A total of 8 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $489M, while the lowest revenue estimate was $456.96M, resulting in an average revenue estimate of $463.98M. In the same quarter a year ago, actual revenue was $398.99MBased on 15 analysts’ estimates, the company’s revenue will be $701.17M in the next fiscal year. The high estimate is $867M and the low estimate is $556.5M.
